Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2015

Open Access 01-12-2015 | Research

Effectiveness of smoking reduction intervention for hardcore smokers

Authors: Tai Hing Lam, Yee Tak Derek Cheung, Doris Yin Ping Leung, Abu Saleh M Abdullah, Sophia Siu Chee Chan

Published in: Tobacco Induced Diseases | Issue 1/2015

Login to get access

Abstract

Background

The prevalence and correlates of hardcore smokers, who have high daily cigarette consumption, no quitting history and no intention to quit, have been studied in several western developed countries, but no previous trials of smoking cessation have tested intervention effectiveness for these smokers. The current study examined if hardcore smokers can benefit from smoking reduction intervention to achieve cessation, and explored the underlying reasons.

Methods

A posteriori analysis was conducted on data from a randomized controlled trial of smoking reduction intervention on 1,154 smokers who did not want to quit. Odds ratios of 7-day point prevalence of abstinence, smoking reduction by at least 50% and quit attempt at the 6-month follow-up comparing subgroups of smokers were analyzed.

Results

In hardcore smokers, the odds ratio comparing the quit rate between the intervention and control group was 4.18 (95% CI: 0.51-34.65), which was greater than non-hardcore smokers (OR = 1.58, 95% CI: 0.98-2.54). The number needed to treat for hardcore and non-hardcore smokers was 8.33 (95% CI: 5.56-16.67) and 16.67 (95% CI: 8.33-233.64), respectively. In smokers who did not have quit attempt experience and those who smoked more than 15 cigarettes daily, the odds ratio comparing intervention and control group was 3.29 (95% CI: 0.72-14.98) and 1.36 (95% CI: 0.78-2.36), respectively.

Conclusions

The a posteriori analysis provided pilot results that smoking reduction intervention may be effective to help hardcore smokers to quit and reduce smoking. Having no previous quit attempt was identified as more important than having large cigarette consumption in explaining the greater effectiveness of the intervention.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. WHO report on the global tobacco epidemic, 2011. Geneva: World Health Organization, 2008; 2011. World Health Organization. WHO report on the global tobacco epidemic, 2011. Geneva: World Health Organization, 2008; 2011.
2.
go back to reference Hyland A, Borland R, Li Q, Yong H-H, McNeill A, Fong GT, et al. Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15 suppl 3:iii83–94.PubMedCentralPubMed Hyland A, Borland R, Li Q, Yong H-H, McNeill A, Fong GT, et al. Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15 suppl 3:iii83–94.PubMedCentralPubMed
3.
go back to reference Emery S, Gilpin EA, Ake C, Farkas AJ, Pierce JP. Characterizing and identifying “Hard-core” smokers: implications for further reducing smoking prevalence. Am J Public Health. 2000;90(3):387–94.CrossRefPubMedCentralPubMed Emery S, Gilpin EA, Ake C, Farkas AJ, Pierce JP. Characterizing and identifying “Hard-core” smokers: implications for further reducing smoking prevalence. Am J Public Health. 2000;90(3):387–94.CrossRefPubMedCentralPubMed
4.
go back to reference Koplan JP, An WK, Lam RMK. Hong Kong: a model of successful tobacco control in China. Lancet. 2010;375(9723):1330–1.CrossRefPubMed Koplan JP, An WK, Lam RMK. Hong Kong: a model of successful tobacco control in China. Lancet. 2010;375(9723):1330–1.CrossRefPubMed
5.
go back to reference Census & Statistics Department (Hong Kong SAR government). Thematic household survey, report no. 53: pattern of smoking. Hong Kong: Census & Statistics Department; 2013. Census & Statistics Department (Hong Kong SAR government). Thematic household survey, report no. 53: pattern of smoking. Hong Kong: Census & Statistics Department; 2013.
6.
go back to reference Leung DYP, Chan SSC, Lam TH. Prevalence and characteristics of hardcore smokers in Hong Kong. Hong Kong: The University of Hong Kong; 2011. Leung DYP, Chan SSC, Lam TH. Prevalence and characteristics of hardcore smokers in Hong Kong. Hong Kong: The University of Hong Kong; 2011.
7.
go back to reference Augustson EM, Marcus SE. Use of the current population survey to characterize subpopulations of continued smokers: a national perspective on the “hardcore” smoker phenomenon. Nicotine Tob Res. 2004;6(4):621–9.CrossRefPubMed Augustson EM, Marcus SE. Use of the current population survey to characterize subpopulations of continued smokers: a national perspective on the “hardcore” smoker phenomenon. Nicotine Tob Res. 2004;6(4):621–9.CrossRefPubMed
8.
go back to reference Costa ML, Cohen JE, Chaiton MO, Ip D, McDonald P, Ferrence R. “Hardcore” definitions and their application to a population-based sample of smokers. Nicotine Tob Res. 2010;12(8):860–4.CrossRefPubMed Costa ML, Cohen JE, Chaiton MO, Ip D, McDonald P, Ferrence R. “Hardcore” definitions and their application to a population-based sample of smokers. Nicotine Tob Res. 2010;12(8):860–4.CrossRefPubMed
9.
go back to reference Jarvis MJ, Wardle J, Waller J, Owen L. Prevalence of hardcore smoking in England, and associated attitudes and beliefs: cross sectional study. BMJ. 2003;326(7398):1061.CrossRefPubMedCentralPubMed Jarvis MJ, Wardle J, Waller J, Owen L. Prevalence of hardcore smoking in England, and associated attitudes and beliefs: cross sectional study. BMJ. 2003;326(7398):1061.CrossRefPubMedCentralPubMed
10.
go back to reference Ferketich AK, Gallus S, Colombo P, Pacifici R, Zuccaro P, La Vecchia C. Hardcore smoking among Italian men and women. Eur J Cancer Prev. 2009;18(2):100–5.CrossRefPubMed Ferketich AK, Gallus S, Colombo P, Pacifici R, Zuccaro P, La Vecchia C. Hardcore smoking among Italian men and women. Eur J Cancer Prev. 2009;18(2):100–5.CrossRefPubMed
12.
go back to reference Carpenter MJ, Hughes JR, Solomon LJ, Callas PW. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol. 2004;72(3):371–81.CrossRefPubMed Carpenter MJ, Hughes JR, Solomon LJ, Callas PW. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol. 2004;72(3):371–81.CrossRefPubMed
13.
go back to reference Etter J-FPMPH, Laszlo ERNBA, Perneger TVMDP. Postintervention effect of nicotine replacement therapy on smoking reduction in smokers who are unwilling to quit: randomized trial. J Clin Psychopharmacol. 2004;24(2):174–9.CrossRefPubMed Etter J-FPMPH, Laszlo ERNBA, Perneger TVMDP. Postintervention effect of nicotine replacement therapy on smoking reduction in smokers who are unwilling to quit: randomized trial. J Clin Psychopharmacol. 2004;24(2):174–9.CrossRefPubMed
14.
go back to reference Chris TB, Jean-Pierre Z, Tobias D, Xandra Van B, Ånnik R, Ake W, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ. 2000;321:329–33.CrossRef Chris TB, Jean-Pierre Z, Tobias D, Xandra Van B, Ånnik R, Ake W, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ. 2000;321:329–33.CrossRef
15.
go back to reference Rennard SI, Glover ED, Leischow S, Daughton DM, Glover PN, Muramoto M, et al. Efficacy of the nicotine inhaler in smoking reduction: a double‐blind, randomized trial. Nicotine Tob Res. 2006;8(4):555–64.CrossRefPubMed Rennard SI, Glover ED, Leischow S, Daughton DM, Glover PN, Muramoto M, et al. Efficacy of the nicotine inhaler in smoking reduction: a double‐blind, randomized trial. Nicotine Tob Res. 2006;8(4):555–64.CrossRefPubMed
16.
go back to reference Batra A, Klingler K, Landfeldt B, Friederich HM, Westin A, Danielsson T. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther. 2005;78(6):689–96.CrossRefPubMed Batra A, Klingler K, Landfeldt B, Friederich HM, Westin A, Danielsson T. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther. 2005;78(6):689–96.CrossRefPubMed
17.
go back to reference Asfar T, Ebbert JO, Klesges RC, Relyea GE. Do smoking reduction interventions promote cessation in smokers not ready to quit? Addict Behav. 2011;36(7):764–8.CrossRefPubMedCentralPubMed Asfar T, Ebbert JO, Klesges RC, Relyea GE. Do smoking reduction interventions promote cessation in smokers not ready to quit? Addict Behav. 2011;36(7):764–8.CrossRefPubMedCentralPubMed
18.
go back to reference Chan SSC, Leung DYP, Abdullah ASM, Wong VT, Hedley AJ, Lam T-H. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking. Addiction. 2011;106(6):1155–63.CrossRefPubMed Chan SSC, Leung DYP, Abdullah ASM, Wong VT, Hedley AJ, Lam T-H. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking. Addiction. 2011;106(6):1155–63.CrossRefPubMed
19.
go back to reference World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
20.
go back to reference Augustson EM, Barzani D, Rutten LJF, Marcus S. Gender differences among hardcore smokers: an analysis of the tobacco use supplement of the current population survey. J Womens Health (15409996). 2008;17(7):1167–73.CrossRef Augustson EM, Barzani D, Rutten LJF, Marcus S. Gender differences among hardcore smokers: an analysis of the tobacco use supplement of the current population survey. J Womens Health (15409996). 2008;17(7):1167–73.CrossRef
21.
go back to reference Ip DT, Cohen JE, Bondy SJ, Chaiton MO, Selby P, Schwartz R, et al. Do components of current ‘hardcore smoker’ definitions predict quitting behaviour? Addiction. 2012;107(2):434–40.CrossRefPubMed Ip DT, Cohen JE, Bondy SJ, Chaiton MO, Selby P, Schwartz R, et al. Do components of current ‘hardcore smoker’ definitions predict quitting behaviour? Addiction. 2012;107(2):434–40.CrossRefPubMed
22.
go back to reference Jarvis MJ, Sims M, Gilmore A, Mindell J. Impact of smoke-free legislation on children’s exposure to secondhand smoke: cotinine data from the Health Survey for England. Tob Control. 2012;21(1):18–23.CrossRefPubMed Jarvis MJ, Sims M, Gilmore A, Mindell J. Impact of smoke-free legislation on children’s exposure to secondhand smoke: cotinine data from the Health Survey for England. Tob Control. 2012;21(1):18–23.CrossRefPubMed
23.
go back to reference Richard JC, David LS. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452–4.CrossRef Richard JC, David LS. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452–4.CrossRef
24.
go back to reference Vangeli E, Stapleton J, Smit ES, Borland R, West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011;106(12):2110–21.CrossRefPubMed Vangeli E, Stapleton J, Smit ES, Borland R, West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011;106(12):2110–21.CrossRefPubMed
25.
go back to reference Jardin BF, Carpenter MJ. Predictors of quit attempts and abstinence among smokers not currently interested in quitting. Nicotine Tob Res. 2012;14(10):1197–204.CrossRefPubMedCentralPubMed Jardin BF, Carpenter MJ. Predictors of quit attempts and abstinence among smokers not currently interested in quitting. Nicotine Tob Res. 2012;14(10):1197–204.CrossRefPubMedCentralPubMed
26.
go back to reference Diemert LM, Bondy SJ, Brown KS, Manske S. Young adult smoking cessation: predictors of quit attempts and abstinence. Am J Public Health. 2013;103(3):449–53.CrossRefPubMedCentralPubMed Diemert LM, Bondy SJ, Brown KS, Manske S. Young adult smoking cessation: predictors of quit attempts and abstinence. Am J Public Health. 2013;103(3):449–53.CrossRefPubMedCentralPubMed
27.
go back to reference Shiffman S, Ferguson SG, Strahs KR. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. Am J Prev Med. 2009;36(2):96–104.e101.CrossRefPubMed Shiffman S, Ferguson SG, Strahs KR. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. Am J Prev Med. 2009;36(2):96–104.e101.CrossRefPubMed
28.
go back to reference Wennike P, Danielsson T, Landfeldt B, Westin Å, Tønnesen P. Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction. 2003;98(10):1395–402.CrossRefPubMed Wennike P, Danielsson T, Landfeldt B, Westin Å, Tønnesen P. Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction. 2003;98(10):1395–402.CrossRefPubMed
29.
go back to reference Bolliger CT, Zellweger J-P, Danielsson T, Biljon XV, Robidou A, Westin Å, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ. 2000;321(321):329–33.CrossRefPubMedCentralPubMed Bolliger CT, Zellweger J-P, Danielsson T, Biljon XV, Robidou A, Westin Å, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ. 2000;321(321):329–33.CrossRefPubMedCentralPubMed
30.
go back to reference Chaiton MO, Cohen JE, Frank J. Population health and the hardcore smoker: Geoffrey Rose revisited. J Public Health Policy. 2008;29(3):307–18.CrossRefPubMed Chaiton MO, Cohen JE, Frank J. Population health and the hardcore smoker: Geoffrey Rose revisited. J Public Health Policy. 2008;29(3):307–18.CrossRefPubMed
31.
go back to reference Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Rockvill: MD: Department of Health and Human Services; 2008. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Rockvill: MD: Department of Health and Human Services; 2008.
Metadata
Title
Effectiveness of smoking reduction intervention for hardcore smokers
Authors
Tai Hing Lam
Yee Tak Derek Cheung
Doris Yin Ping Leung
Abu Saleh M Abdullah
Sophia Siu Chee Chan
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2015
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-015-0034-y

Other articles of this Issue 1/2015

Tobacco Induced Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine